학술논문
AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgkin Lymphoma and CD30 +Peripheral T-Cell Lymphoma: A Phase 2 Study (LuminICE)
Document Type
Article
Author
Source
Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p4855-4855, 1p
Subject
Language
ISSN
00064971; 15280020
Abstract
Background and Significance